2- methyl- N- ((2'- (pyrrolidin- 1- ylsulfonyl)biphenyl- 4- yl)methyl)propan- 1- amine

has antidepressant activity; structure in first source

Also Known As:

2-methyl-N-(2'-(pyrrolidinyl-1-ylsulfonyl)-(1,1'-biphenyl)-4-yl)propan-1-amine; PF 4455242; PF-04455242; PF-4455242; PF4455242

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Weight Gain 03/14/2022 - "These effects were also observed following central pharmacological blockade of the k-OR system using the k-OR-selective antagonist PF-04455242 in wild type mice, in which we also observed a decrease in OVX-induced weight gain associated with increased UCP1 positive immunostaining in brown adipose tissue (BAT) and browning of white adipose tissue (WAT). "
2.	Body Weight (Weight, Body) 01/01/2019 - "PF-4455242 was intravenously infused for 4 h (1 or 10 μmol/kg body weight/4 h) or as a single subcutaneous injection (1 or 10 μmol/kg body weight). "

1.	Subcutaneous Injections